Illkirch, France

Stephan Schann

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Strasbourg, FR (2001)
  • Graffenstaden, FR (2015)
  • Illkirch Graffenstaden, FR (2016 - 2019)
  • Illkirch, FR (2015 - 2022)

Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Stephan Schann

Introduction

Stephan Schann is a notable inventor based in Illkirch, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of nine patents to his name, Schann's work focuses on addressing various medical conditions through innovative chemical solutions.

Latest Patents

One of Schann's latest patents involves the development of 5-azaindazole derivatives as adenosine receptor antagonists. This invention relates to novel compounds that have been found to be highly effective dual A/A adenosine receptor antagonists. These compounds can be utilized as therapeutic agents, particularly in the treatment or prevention of hyperproliferative or infectious diseases or disorders.

Another significant patent from Schann includes substituted heterocyclic compounds as allosteric modulators of group II metabotropic glutamate receptors. This invention provides novel heterocyclic compounds that can act as modulators of nervous system receptors sensitive to glutamate. These compounds are particularly suitable for the treatment and/or prophylaxis of acute and chronic neurological and/or psychiatric disorders.

Career Highlights

Throughout his career, Stephan Schann has worked with various companies, including Domain Therapeutics and Kaldi Pharma. His expertise in pharmaceutical innovation has allowed him to contribute to the development of groundbreaking therapeutic solutions.

Collaborations

Some of Schann's notable coworkers include Stanislas Mayer and Baptiste Manteau. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical compounds.

Conclusion

Stephan Schann's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…